Vaginal Microbiota Dysbiosis and the Role of Opportunistic Microorganisms in Gynecological Infections
Keywords:
Vaginal Microbiota, Dysbiosis, Opportunistic Microorganisms, Bacterial Vaginosis, Candidiasis, Lactobacillus, Biofilm, Gynecological Infections, Probiotics, Antibiotic ResistanceAbstract
Vaginal microbiota represents one of the major physiological defense mechanisms of the female reproductive system. Normal vaginal microflora is predominantly composed of Lactobacillus species, which maintain an acidic environment and inhibit the growth of pathogenic microorganisms. Disruption of the vaginal microbiota balance, known as dysbiosis, leads to the activation of opportunistic microorganisms and contributes to the development of various gynecological infections. This article analyzes the etiopathogenesis, microbiological characteristics, and the role of opportunistic microorganisms in gynecological diseases associated with vaginal dysbiosis. The study examined the major microorganisms involved in bacterial vaginosis, candidiasis, and mixed infections, as well as their biofilm-forming abilities and mechanisms of antibiotic resistance. In addition, the influence of immune status, hormonal changes, uncontrolled antibiotic use, and hygienic factors on the development of dysbiosis was investigated. The article highlights modern preventive and therapeutic approaches aimed at restoring vaginal microbiota, including probiotic therapy and antimicrobial agents. The findings of this study have important scientific and practical significance for the early diagnosis and effective treatment of gynecological infections.
References
[1] J. D. Sobel, “Vulvovaginal candidosis,” The Lancet, 2021.
[2] D. H. Martin, “The microbiota of the vagina and its influence on women’s health and disease,” American Journal of Medical Sciences, 2020.
[3] C. Mitchell and J. Marrazzo, “Bacterial vaginosis and the cervicovaginal immune response,” American Journal of Reproductive Immunology, 2022.
[4] World Health Organization, Guidelines for the Management of Sexually Transmitted and Reproductive Tract Infections. Geneva, 2021.
[5] S. Boris and C. Barbés, “Role played by lactobacilli in controlling the population of vaginal pathogens,” Microbes and Infection, 2020.
[6] M. I. Petrova et al., “Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health,” Frontiers in Physiology, 2021.
[7] G. F. Brooks, Jawetz, Melnick & Adelberg’s Medical Microbiology. New York: McGraw-Hill Education, 2022.
[8] P. R. Murray, Medical Microbiology. Amsterdam: Elsevier, 2023.
[9] Centers for Disease Control and Prevention, Sexually Transmitted Infections Treatment Guidelines. Atlanta, 2022.
[10] W. Mendling, “Vaginal Microbiota,” Advances in Experimental Medicine and Biology, 2020.
[11] R. A. Larsen and M. Monif, “Understanding the vaginal flora in health and disease,” Clinical Obstetrics and Gynecology, vol. 64, no. 2, pp. 215–223, 2021.
[12] A. O. Eschenbach, “Bacterial vaginosis: resistance, recurrence, and treatment strategies,” Clinical Infectious Diseases, vol. 73, no. 4, pp. 145–152, 2021.
[13] B. Ravel et al., “Vaginal microbiome of reproductive-age women,” Proceedings of the National Academy of Sciences, vol. 118, no. 15, 2020.
[14] L. Petricevic and W. Witt, “The role of probiotics in vaginal health,” Nutrients, vol. 12, no. 8, pp. 1–14, 2020.
[15] S. L. Hillier, “Diagnostic microbiology of bacterial vaginosis,” American Journal of Obstetrics and Gynecology, vol. 224, no. 2, pp. 95–101, 2021.
